Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2014 Oct 14:15:166.
doi: 10.1186/1471-2369-15-166.

Your Path to Transplant: a randomized controlled trial of a tailored computer education intervention to increase living donor kidney transplant

Amy D Waterman  1 , Mark L Robbins, Andrea L Paiva, John D Peipert, Crystal S Kynard-Amerson, Christina J Goalby, LaShara A Davis, Jessica L Thein, Emily A Schenk, Kari A Baldwin, Stacy L Skelton, Nicole R Amoyal, Leslie A Brick
Affiliations
Randomized Controlled Trial

Your Path to Transplant: a randomized controlled trial of a tailored computer education intervention to increase living donor kidney transplant

Amy D Waterman et al. BMC Nephrol. .

Abstract

Background: Because of the deceased donor organ shortage, more kidney patients are considering whether to receive kidneys from family and friends, a process called living donor kidney transplantation (LDKT). Although Blacks and Hispanics are 3.4 and 1.5 times more likely, respectively, to develop end stage renal disease (ESRD) than Whites, they are less likely to receive LDKTs. To address this disparity, a new randomized controlled trial (RCT) will assess whether Black, Hispanic, and White transplant patients' knowledge, readiness to pursue LDKT, and receipt of LDKTs can be increased when they participate in the Your Path to Transplant (YPT) computer-tailored intervention.

Methods/design: Nine hundred Black, Hispanic, and White ESRD patients presenting for transplant evaluation at University of California, Los Angeles Kidney and Pancreas Transplant Program (UCLA-KPTP) will be randomly assigned to one of two education conditions, YPT or Usual Care Control Education (UC). As they undergo transplant evaluation, patients in the YPT condition will receive individually-tailored telephonic coaching sessions, feedback reports, video and print transplant education resources, and assistance with reducing any known socioeconomic barriers to LDKT. Patients receiving UC will only receive transplant education provided by UCLA-KPTP. Changes in transplant knowledge, readiness, pros and cons, and self-efficacy to pursue LDKT will be assessed prior to presenting at the transplant center (baseline), during transplant evaluation, and 4- and 8-months post-baseline, while completion of transplant evaluation and receipt of LDKTs will be assessed at 18-months post-baseline. The RCT will determine, compared to UC, whether Black, Hispanic, and White patients receiving YPT increase in their readiness to pursue LDKT and transplant knowledge, and become more likely to complete transplant medical evaluation and pursue LDKT. It will also examine how known patient, family, and healthcare system barriers to LDKT act alone and in combination with YPT to affect patients' transplant decision-making and behavior. Statistical analyses will be performed under an intent-to-treat approach.

Discussion: At the conclusion of the study, we will have assessed the effectiveness of an innovative and cost-effective YPT intervention that could be utilized to tailor LDKT discussion and education based on the needs of individual patients of different races in many healthcare settings.

Trial registration: ClinicalTrials.gov, number NCT02181114.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Example feedback reports.
Figure 2
Figure 2
Your Path to Transplant study design flowchart.
See this image and copyright information in PMC

References

    1. Neipp M, Karavul B, Jackobs S, Meyer zu Vilsendorf A, Richter N, Becker T, Schwarz A, Klempnauer J. Quality of life in adult transplant recipients more than 15 years after kidney transplantation. Transplantation. 2006;81(12):1640–1644. doi: 10.1097/01.tp.0000226070.74443.fb. - DOI - PubMed
    1. USRDS 2013 Annual Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. [http://usrds.org]
    1. Loubeau PR, Loubeau JM, Jantzen R. The economics of kidney transplantation versus hemodialysis. Prog Transplant. 2001;11(4):291–297. - PubMed
    1. de Graaf OW, Bogetti-Dumlao A. Living donors' perception of their quality of health after donation. Prog Transplant. 2001;11(2):108–115. - PubMed
    1. Tarantino A. Why should we implement living donation in renal transplantation? Clin Nephrol. 2000;53(4):55–63. - PubMed
Pre-publication history
    1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2369/15/166/prepub

Publication types

Associated data